German Merck Plans US$107.67 million Plant in China
Merck KGaA plans to construct a new plant in China to manufacture diabetes drugs and address critical healthcare needs of the Chinese population.
Location
The new plant is planned to be built in Shaghai, China covering an area of 40,000 square meters. The plant will have a room for a 20,000-square-meter expansion.
Budget
The US$107.67 million (€80 million) plant will manufacture diabetes drugs namely Glucophage, Concor, Euthyrox and also drugs for heart and thyroid conditions.
Schedule
The construction work is scheduled to start in September 2014 and expected to be completed in 2016. Merck plans to start commercial production in 2017.
Specifications Table:
- Company Name
- Merck KGaA
- Location
- Shanghai, China
- Construction Type
- New PLant
- Date of Start
- September 2014
- Date of Completion
- 2016
- Estimated Investment:
- US$107.67 million (€80 million)
- Key players
- Sponsors/Partners
